Yahoo Sports’ Caroline Fenton spoke with the Philadelphia Eagles tight end about the team’s championship win, his quarterback ...
Urea is an organic compound that touts impressive skin health benefits, particularly when it comes to hydration and ...
Jeffrey Stark, MD, vice president and head of medical immunology at UCB, discusses tailored dosing of bimekizumab-bkzx (Bimzelx) for various inflammatory conditions, highlighting its 5 FDA approvals ...
More than 125 million people worldwide suffer from some form of psoriasis. If you’ve struggled with your skin health this ...
Q. Is there any cure for psoriasis? A. There’s no cure for psoriasis yet, but there are many ways to get relief from the symptoms of this troublesome disease. Psoriasis is one of the most ...
5d
Hosted on MSNArcutis Soared In 2024, Blazing Trails In Dermatology. Why Its CEO Eyes Bigger Gains.Arcutis Biotherapeutics has a lofty goal for 2025 — and it could help Arcutis stock continue a massive run that helped shares ...
January started the year off strong, with several business updates, long-term clinical trial results on multiple biosimilars, ...
Live Updates Deep Dive into ABBV's Earnings Call 11:53 am Looking through AbbVie’s earnings call, these growth prospects stood out: 1. Skyrizi & Rinvoq Set to Dominate Immunology Market 2025 revenue ...
The following is a summary of “Bimekizumab efficacy and safety through 3 years in patients with moderate to severe plaque ...
Deucravacitinib significantly improved skin-related quality of life of patients with moderate to severe plaque psoriasis, according to a poster presented at Maui Derm Hawaii 2025. A total of 40.6% to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results